Speaker Name: Prof. Antonio Ceriello, Head of the Diabetes Department, IRCCS MultiMedica, Milan, Italy.

Explore this session to:

• Understand CKM syndrome as an interrelated spectrum linking T2DM, CKD, HF, obesity, and ASCVD.
• Recognize the rising diabetes and obesity burden in India and the need for earlier screening and risk-factor control.
• Gain insight into how early T2DM diagnosis and intensive glycemic control may reduce long-term microvascular and macrovascular complications through metabolic memory.
• Interpret the role of 1-h plasma glucose during OGTT for earlier identification of intermediate hyperglycemia and future T2DM risk.
• Apply current ADA, EASD, and IDF recommendations on prioritizing SGLT2 inhibitors, GLP-1 RAs, and combination therapy in patients with CKD, HF, obesity, or ASCVD.